Pluri's Ever After Foods Acquires Fishway, Adds $2M SAFE Investment
PLUR is trading near its 52-week low of $1.45 (10% above the low) on elevated volume (1.8× avg).
Summary
Ever After Foods, Pluri's 69%-owned subsidiary, agreed to acquire Fishway BV and secured a $2.0 million SAFE investment. Pluri's ownership in EAF will fall to about 58% after closing.
Key Events · M&A and Partnerships · PLUR
-
EAF Acquires Fishway BV
Ever After Foods, Pluri's indirect majority-owned subsidiary, entered into a share purchase agreement to acquire all outstanding share capital of Fishway BV, a Belgian company with cell lines and culture media for cultivated seafood.
-
$2.0M SAFE Investment
In connection with the transaction, certain Fishway sellers agreed to invest $2.0 million in EAF through a simple agreement for future equity (SAFE).
-
Pluri Ownership Dilution
Pluri's indirect ownership in EAF is expected to decrease from approximately 69% to approximately 58% following completion of the transaction.
-
Closing Expected Within 30 Days
The transaction is expected to close within 30 days of the share purchase agreement dated August 12, 2026, subject to customary closing conditions.
Analysis · PLUR · Life Sciences
Pluri's majority-owned subsidiary Ever After Foods (EAF) is acquiring Fishway BV, a Belgian company with cell lines and culture media for cultivated seafood. The deal includes a $2.0 million SAFE investment from Fishway sellers. Pluri's indirect ownership in EAF will drop from about 69% to 58%, diluting Pluri's stake but bringing in capital and European presence. This comes as Pluri faces a Nasdaq delisting notice and acute liquidity concerns, making the $2M investment and strategic expansion notable.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 29.7% of the 1528 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $1.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.3M. The 52-week trading range was $1.45 to $5.68. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.